Capstone Investment Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-868,549
| Closed | -$160M | – | 1135 |
|
|
2021
Q2 | $160M | Sell |
868,549
-308,950
| -26% | -$56.8M | 0.36% | 3 |
|
|
2021
Q1 | $180M | Buy |
1,177,499
+979,455
| +495% | +$150M | 0.53% | 2 |
|
|
2020
Q4 | $30.9M | Buy |
+198,044
| New | +$30.9M | 0.1% | 19 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 637 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 602 |
|
|
2020
Q1 | – | Sell |
-18,634
| Closed | -$2.02M | – | 578 |
|
|
2019
Q4 | $2.02M | Sell |
18,634
-9,287
| -33% | -$1M | 0.01% | 182 |
|
|
2019
Q3 | $2.74M | Buy |
27,921
+22,173
| +386% | +$2.17M | 0.02% | 105 |
|
|
2019
Q2 | $753K | Buy |
5,748
+4,737
| +469% | +$621K | 0.01% | 263 |
|
|
2019
Q1 | $137K | Sell |
1,011
-8,712
| -90% | -$1.18M | ﹤0.01% | 300 |
|
|
2018
Q4 | $947K | Buy |
9,723
+5,651
| +139% | +$550K | 0.01% | 171 |
|
|
2018
Q3 | $566K | Buy |
+4,072
| New | +$566K | 0.01% | 220 |
|
|
2017
Q2 | – | Sell |
-21,619
| Closed | -$2.62M | – | 856 |
|
|
2017
Q1 | $2.62M | Buy |
+21,619
| New | +$2.62M | 0.07% | 161 |
|
|
2016
Q3 | – | Sell |
-8,400
| Closed | -$980K | – | 833 |
|
|
2016
Q2 | $980K | Sell |
8,400
-17,375
| -67% | -$2.03M | 0.02% | 273 |
|
|
2016
Q1 | $3.59M | Buy |
+25,775
| New | +$3.59M | 0.11% | 88 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 308 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 185 |
|